These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9196857)

  • 1. Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion.
    Grover GJ
    Can J Physiol Pharmacol; 1997 Apr; 75(4):309-15. PubMed ID: 9196857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia.
    Grover GJ
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S18-27. PubMed ID: 7898104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
    Atwal KS
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S12-7. PubMed ID: 7898103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
    Grover GJ; D'Alonzo AJ; Hess T; Sleph PG; Darbenzio RB
    Cardiovasc Res; 1995 Nov; 30(5):731-8. PubMed ID: 8595620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
    Grover GJ; McCullough JR; D'Alonzo AJ; Sargent CA; Atwal KS
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):40-50. PubMed ID: 7723352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
    Grover GJ; D'Alonzo AJ; Garlid KD; Bajgar R; Lodge NJ; Sleph PG; Darbenzio RB; Hess TA; Smith MA; Paucek P; Atwal KS
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1184-92. PubMed ID: 11356945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle.
    Carr CS; Yellon DM
    Basic Res Cardiol; 1997 Aug; 92(4):252-60. PubMed ID: 9342432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Potential role of ATP-sensitive K+ channels in ischemia- and reperfusion-induced arrhythmias].
    Nakaya H
    Kokyu To Junkan; 1993 Jun; 41(6):512-20. PubMed ID: 8337509
    [No Abstract]   [Full Text] [Related]  

  • 9. Essential role of nucleotide diphosphates in nicorandil-mediated activation of cardiac ATP-sensitive K+ channel. A comparison with pinacidil and lemakalim.
    Shen WK; Tung RT; Machulda MM; Kurachi Y
    Circ Res; 1991 Oct; 69(4):1152-8. PubMed ID: 1834361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
    Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
    J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP sensitive potassium channel openers are of potential benefit in ischaemic heart disease.
    Cavero I; Premmereur J
    Cardiovasc Res; 1994 Jan; 28(1):32-3. PubMed ID: 8111790
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological properties of ATP-sensitive K+ channels in mammalian skeletal muscle cells.
    Allard B; Lazdunski M
    Eur J Pharmacol; 1993 Jun; 236(3):419-26. PubMed ID: 8359200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs.
    Auchampach JA; Gross GJ
    Eur Heart J; 1993 Jul; 14 Suppl B():10-5. PubMed ID: 8370365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular pharmacology of ATP-sensitive K+ channels: interactions between glyburide and K+ channel openers.
    Meisheri KD; Khan SA; Martin JL
    J Vasc Res; 1993; 30(1):2-12. PubMed ID: 8435468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?
    Das B; Sarkar C
    Life Sci; 2005 Jul; 77(11):1226-48. PubMed ID: 15964023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-Sensitive potassium channels: a review of their cardioprotective pharmacology.
    Grover GJ; Garlid KD
    J Mol Cell Cardiol; 2000 Apr; 32(4):677-95. PubMed ID: 10756123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and properties of an ATP-sensitive K+ current in rabbit sino-atrial node pacemaker cells.
    Han X; Light PE; Giles WR; French RJ
    J Physiol; 1996 Jan; 490 ( Pt 2)(Pt 2):337-50. PubMed ID: 8821133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of ATP-sensitive potassium channels in myocardial ischemia: pharmacology and implications for the future.
    Grover GJ
    EXS; 1996; 76():313-24. PubMed ID: 8805803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effects of nicorandil in rabbits anaesthetized with halothane: potentiation of ischaemic preconditioning via KATP channels.
    Nakae I; Takaoka A; Mitsunami K; Yabe T; Ito M; Masayuki ; Takahashi ; Matsumoto T; Omura T; Yokohama H; Kinoshita M
    Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):810-7. PubMed ID: 11022974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of a pharmacologic interaction between ATP-sensitive potassium channels and adenosine A1 receptors in ischemic rat hearts.
    Grover GJ; Baird AJ; Sleph PG
    Cardiovasc Res; 1996 Apr; 31(4):511-7. PubMed ID: 8689642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.